FUJIFILM Diosynth and Regeneron Sign $3Billion 10-Year U.S. Deal
April 22, 2025
Agreement secures additional U.S. manufacturing capacity to help ensure patient access to medicine FUJIFILM Diosynth Biotechnologies, a world-leading contract development and manufacturing organization for biologics,